Athanassos Argiris, MD, of the Thomas Jefferson University, Philadelphia, PA, gives an overview of some of the interesting recent and current studies in head and neck cancer. These include a study in nasopharyngeal cancer that looks into the role of induction therapy. Another interesting trial compares two different schedules of cisplatin. Furthermore, he explains that trials over recent years we have shown very encouraging results with immune checkpoint inhibitors. There have been promising results in the second line treatment setting and now those drugs have been moved to the first line treatment as well as being used in combination with radiotherapy and chemotherapy. There are currently many more studies underway more interesting data in head and neck cancers will be seen in the near future.
Recorded at the American Society of Oncology (ASCO) 2017 Annual Meeting held in Chicago, IL.